Physician profile
Kirk William Steehler
NPI 1588615447
$3,008.20
in general payments reported to CMS, 2019-2025
22 companies · $882 in 2025
The $882 reported for 2025 was more than what 83% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $322 · 2021: $132 · 2022: $97.76 · 2023: $635 · 2024: $759 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,275.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $598.28 | 2022-2025 | Nucala |
| Genzyme Corporation | $355.33 | 2021-2025 | |
| Inspire Medical Systems, INC. | $349.44 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $230.33 | 2023-2025 | Dupixent |
| Musculoskeletal Transplant Foundation INC. | $212.33 | 2020 | |
| Smith+Nephew, INC. | $210.50 | 2023-2025 | Grafix Pl, Stravix Pl, Stravix |
| Ars Pharmaceuticals Operations, INC. | $164.09 | 2025 | Neffy |
| Cochlear Americas | $149.64 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Ambu INC. | $124.86 | 2024 | |
| Axogen | $109.68 | 2020 | |
| Checkpoint Surgical, INC | $109.32 | 2021 | |
| Aerin Medical INC. | $100.99 | 2019 | |
| Acclarent, INC | $79.72 | 2019 | |
| Integra Lifesciences Corporation | $48.45 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Optinose US, INC. | $31.22 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27.84 | 2023 | |
| Stryker Corporation | $26.07 | 2024 | Scopis Ent |
| Depuy Synthes Sales INC. | $19.01 | 2023 | Matrixwave, Matrixmidface, Trumatch |
| Amgen INC. | $17.01 | 2025 | Tezspire |
| Davol INC. | $16.84 | 2022 | |
| Alk-Abello, INC | $15.33 | 2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Phathom Pharmaceuticals, INC. | $11.92 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Steehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.